Dendreon Pharmaceuticals

Dendreon Pharmaceuticals

Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market.

Dendreon was founded on the belief that immunotherapy made from a patient’s own cells will transform disease treatment. Our product PROVENGE® (sipuleucel-T) was the first FDA-approved immunotherapy to harness the innate benefits of personalized cellular treatment made from a patient’s own immune cells.

Now Dendreon is helping to advance other cell therapies from clinic to market by leveraging its development and commercialization experience.

Yes

Genitourinary Cancer, Metastatic Disease, Drug Development, Immunotherapy, Pharmaceutical